Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
31 /100
MEDIUM RISK
Score updated Oct 13, 2026

GRDN — Guardian Pharmacy Services, Inc. Dilution Risk Tracker

Track GRDN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track GRDN — Get alerts when the score changes →

As of October 13, 2026, Guardian Pharmacy Services, Inc. (GRDN) has a DilutionWatch DilutionScore of 31/100, rated MEDIUM dilution risk. Guardian Pharmacy Services, Inc. has a market capitalization of $2.01B, 49.78M shares outstanding, 170 institutional holders tracked. Stored dilution-related fields include ATM program capacity of $186.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
60
💰Cash Runway—
📊 Float Risk
25
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 9%
💰 Capital Raise model 18%
• Active ATM program with $186M remaining capacity
🔔 Track GRDN — Get forecast alerts →

Market Data

Market Cap$2.01B
Shares Outstanding49.78M
Float31.99M
Cash$89.81M
Debt$28.66M
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore31/100DilutionWatch score record
Shares Outstanding49.78MVerified float table or market cache
Public Float31.99MVerified float table or market cache
Market Cap$2.01BMarket data cache
Cash RunwayNot applicable / unavailableDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM Capacity$186.00MSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 5.

Recent SEC source mix: 4 5.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 55.4% shares (2026Q1 vs prior)
170 institutional holders · 31.40M shares
#1 Woodline Partners LP 2.61M shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 2.45M shares
#3 FMR LLC 2.36M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest2.48M
Days to Cover3.1
% of Float7.8%
FINRA data as of Sep 30, 2026

Recent SEC Activity

4 INSIDER TRANSACTION 2026-03-31
4 INSIDER TRANSACTION 2026-03-31
4 INSIDER TRANSACTION 2026-03-31
4 INSIDER TRANSACTION 2026-03-31
4 INSIDER TRANSACTION 2026-03-31
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual GRDN Dilution Snapshot

Guardian Pharmacy Services, Inc. (GRDN) has a DilutionScore of 31/100, rated Medium dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

GRDN's DilutionScore is currently 31/100 (Medium risk), with 2 score changes tracked over 89 days. The score deteriorated from 43/100 (Medium risk).

Period Score Risk Level Duration
Oct 10 – Oct 13, 202631/100MEDIUM4 days
Jul 17 – Oct 09, 202643/100MEDIUM84 days
Jul 16, 202644/100MEDIUM1 day

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

GRDN shares outstanding have increased 37.3% from 36.25M (Mar 2026) to 49.78M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 12, 202649.78M31.99M▲ 73.21%
Apr 26, 202637.28M18.47M▼ 3.26%
Apr 13, 202637.28M19.09M▼ 34.56%
Mar 27, 202637.28M29.17M▲ 23.81%
Mar 13, 202636.25M23.56M▲ 1.83%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track GRDN Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment GRDN files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking GRDN — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for GRDN
GRDN FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.